Dec 18, 2025 03:00AM
Dec 18, 2025 03:00AM
Nov 3, 2025 08:33AM
Nov 3, 2025 07:00AM
Oct 3, 2023 04:50PM
Apr 26, 2023 09:04AM
Dec 8, 2021 07:02AM Takeda Pharmaceutical (TAK) Announces Publication of SOLSTICE Phase 3 Trial for LIVTENCITY in Post-Transplant Recipients With Cytomegalovirus Infection
Dec 8, 2021 07:00AM
Oct 8, 2021 05:41AM
Oct 7, 2021 06:15PM
Jun 7, 2021 08:00AM
May 21, 2021 06:18AM
May 21, 2021 04:30AM
Mar 15, 2021 09:10AM Takeda (TAK) Subgroup Analysis from Phase 3 Clinical Trial Supports Efficacy of Maribavir Over Conventional Therapies in Transplant Recipients With Cytomegalovirus Infection
Mar 15, 2021 09:06AM
Feb 12, 2021 06:00AM
May 14, 2020 12:00PM

68,144 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All